Micron and Microsoft Announce Collaboration to Help Improve Internet of Things Security
Apr 24, 2017 12:02 pm UTC| Business
HANNOVER, Germany, April 24, 2017 -- Micron Technology (Nasdaq:MU) and Microsoft today announced a collaboration that aims to address the major challenge of providing trusted computing models for IoT deployments in...
Apr 24, 2017 12:02 pm UTC| Business
TUCSON, Ariz., April 24, 2017 -- HTG Molecular Diagnostics, Inc. (Nasdaq:HTGM), a provider of instruments, reagents and services for molecular profiling applications, announced that it has entered into a research...
Apr 24, 2017 12:02 pm UTC| Business
TUCSON, Ariz., April 24, 2017 -- HTG Molecular Diagnostics, Inc. (Nasdaq:HTGM), a provider of instruments, reagents and services for molecular profiling applications, announced that it has entered into a research...
Apr 24, 2017 12:02 pm UTC| Business
TUCSON, Ariz., April 24, 2017 -- HTG Molecular Diagnostics, Inc. (Nasdaq:HTGM), a provider of instruments, reagents and services for molecular profiling applications, announced that it has entered into a research...
Mustang Bio Announces Appointment of Manuel Litchman, M.D., as President and Chief Executive Officer
Apr 24, 2017 12:02 pm UTC| Business
NEW YORK, April 24, 2017 -- Mustang Bio, Inc. (“Mustang”), a Fortress Biotech (NASDAQ:FBIO) Company, today announced that Manuel Litchman, M.D., has been appointed President and Chief Executive Officer. Dr. Litchman has...
Mustang Bio Announces Appointment of Manuel Litchman, M.D., as President and Chief Executive Officer
Apr 24, 2017 12:02 pm UTC| Business
NEW YORK, April 24, 2017 -- Mustang Bio, Inc. (“Mustang”), a Fortress Biotech (NASDAQ:FBIO) Company, today announced that Manuel Litchman, M.D., has been appointed President and Chief Executive Officer. Dr. Litchman has...
Mustang Bio Announces Appointment of Manuel Litchman, M.D., as President and Chief Executive Officer
Apr 24, 2017 12:02 pm UTC| Business
NEW YORK, April 24, 2017 -- Mustang Bio, Inc. (“Mustang”), a Fortress Biotech (NASDAQ:FBIO) Company, today announced that Manuel Litchman, M.D., has been appointed President and Chief Executive Officer. Dr. Litchman has...